Inventor
Zhonghao LIU
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07KPeptides33%
PatentTitleYear
11,845,802Combination therapy with a glucagon receptor (GCGR) antibody and an anti-CD3 antibody202311,767,359C3-binding agents and methods of use thereof202311,732,049Methods of reducing or lowering blood glucose levels in a human subject by administering an antibody that specifically binds human glucagon receptor202311,566,067Methods of lowering triglyceride levels with an ANGPTL8-binding antibody or antigen-binding fragment thereof202311,136,381Anti-C3 antibodies2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2023Patents assigned to NGM BIOPHARMACEUTICALS INC (5)· patent assignee history
2021–2023Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NGM BIOPHARMACEUTICALS INC | 5 | 2021–2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2021–2023 |